1/2

Export Ready

Dactinomycin Injection

Name: Dactinomycin Injection
SKU: 8501969
Availability: InStoreOnly

Sold by AYURSATVA PHARMA LLP · Raigad, Maharashtra, India

Price

Price on request

In stock

Inclusive of all taxes

Minimum order: 1 Centimetre

Export Snapshot

MOQ

1 Centimetre

Lead time

On request

Packaging

Standard export packaging

Shelf life / longevity

As per product specification

HS Code

On request

Origin

India

Port of dispatch

On request

Export markets served

Global markets

Values shown are for AYURSATVA PHARMA LLP.

Compliance & Certifications

Suitable for

Importers · Distributors · Wholesalers

Raigad Dispatch on request Verified seller

AYURSATVA PHARMA LLP

Verified seller · Raigad, Maharashtra, India

Registered address: RAIGAD, India.

View profile All products

Established

Not shared

Employees

–

GST

27ACGFA6465R1ZM

IEC code

Not shared

Export markets

Global markets

GlobalLinker Member Since

Not shared

Turnover

Incorporation Type

On request

Verified Seller

Product details

What are the specifications of this product?

Overview

Dactinomycin is used in the treatment of testicular cancer, Wilms' tumor, gestational trophoblastic neoplasia and Ewing's sarcoma.

Product Description

Dactinomycin is used in the treatment of testicular cancer, Wilms' tumor, gestational trophoblastic neoplasia and Ewing's sarcoma.

Description provided by AYURSATVA PHARMA LLP.

Specifications

Concentration	Typically 0.5 mg/mL or as specified by manufacturer
Dosage Form	Injection
Volume per vial	Variable - commonly 1 mL or 2 mL vials
Shelf Life	Refer to manufacturer label, generally 2-3 years
Manufacturer Compliance	Manufactured under GMP conditions
Storage Temperature	15°C to 30°C
Pediatric Use	Dosage and usage under specialist supervision
Color	Clear to slightly yellow solution
pH Range	Approximately 4.5 to 6.5

Use cases

Category	Pharmaceuticals > Oncology Drugs > Antineoplastic Agents > Cytotoxic Drugs > Dactinomycin Injection
Primary application	Wholesale, distribution, and international sourcing
Brand	Not specified
Product type	Product

Logistics & handling

Lead time	On request
Packaging	As per buyer requirement
Storage condition	As recommended by supplier
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 Centimetre
Lead time	On request
Payment terms	As per negotiated commercial agreement.
Checkout type	enquiry

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing Dactinomycin Injection. Answers compiled from verified sellers' commercial terms and platform data.

Q: What cancers can Dactinomycin Injection be specifically used to treat?

A: Dactinomycin Injection is specifically indicated for treatment of testicular cancer, Wilms' tumor, gestational trophoblastic neoplasia, and Ewing's sarcoma.

Q: How is Dactinomycin Injection administered clinically?

A: It is administered via intravenous injection under strict medical supervision, often as part of combination chemotherapy protocols.

Q: Are there storage requirements for Dactinomycin Injection to maintain efficacy?

A: Yes, the injection must be stored at controlled room temperature, between 15°C to 30°C, and protected from light to maintain its stability and efficacy.

Q: Is Dactinomycin Injection suitable for pediatric cancer treatment?

A: Dactinomycin Injection can be used in pediatric cancer cases like Wilms' tumor but dosage and administration must be closely monitored by oncology specialists.

Q: Does this product require any special certification to be sold on the B2B marketplace?

A: Yes, Dactinomycin Injection requires special certification such as a valid manufacturing license and compliance with CDSCO and GMP standards to be listed legally on the marketplace.

Q: What quality controls ensure the safety and potency of the Dactinomycin Injection?

A: The product is manufactured under GMP conditions with strict sterility testing, accurate dosage formulation, and expiry labeling to guarantee safety and potency.

Question not answered? Ask sellers directly — typical response within 4 hours.